ロード中...
Rev7 and 53BP1/Crb2 prevent RecQ helicase-dependent hyper-resection of DNA double-strand breaks
Poly(ADP ribose) polymerase inhibitors (PARPi) target cancer cells deficient in homology-directed repair of DNA double-strand breaks (DSBs). In preclinical models, PARPi resistance is tied to altered nucleolytic processing (resection) at the 5’ ends of a DSB. For example, loss of either 53BP1 or Rev...
保存先:
| 出版年: | eLife |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
eLife Sciences Publications, Ltd
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5945276/ https://ncbi.nlm.nih.gov/pubmed/29697047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.33402 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|